Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients.

Maria Dioverti Prono David C GastonC Paul MorrisCarol Ann HuffTania JainRichard JonesViki AndersHoward LedermanJacqueline SaundersHeba H MostafaRobin K Avery

Published in: Open forum infectious diseases (2022)

Profoundly B-cell-depleted patients can have prolonged severe acute respiratory syndrome coronavirus 2 infections with evidence of active viral replication, due to inability to mount an adequate humoral response to clear the virus. We present 3 B-cell-depleted patients with prolonged coronavirus disease 2019 infection who were successfully treated with a combination of casirivimab/imdevimab and remdesivir.

Keyphrases

respiratory syndrome coronavirus
coronavirus disease
end stage renal disease
combination therapy
ejection fraction
sars cov
newly diagnosed
peritoneal dialysis
immune response